tetraethylammonium has been researched along with Fragile X Syndrome in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Fragile X Syndrome: A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, PY | 1 |
| Sojka, D | 1 |
| Klyachko, VA | 1 |
1 other study available for tetraethylammonium and Fragile X Syndrome
| Article | Year |
|---|---|
Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome.
Topics: Animals; Animals, Newborn; Calcium; Disease Models, Animal; Electric Stimulation; Excitatory Postsyn | 2011 |